Dr Liza Vergara

Chow, Josephine S. F., Boudville, Neil, Cho, Yeoungjee, Palmer, Suetonia, Pascoe, Elaine M., Hawley, Carmel M., Reidlinger, Donna M., Hickey, Laura E., Stastny, Ruth, Valks, Andrea, Vergara, Liza, Movva, Ramya, Kiriwandeniya, Charani, Candler, Hayley, Mihala, Gabor, Buisman, Bernadette, Equinox, Keri-Lu, Figueiredo, Ana E., Fuge, Trudi, Howard, Kirsten, Howell, Martin, Jaure, Allison, Jose, Matthew D., Lee, Anna, Miguel, Susana S., Moodie, Jo-anne, Nguyen, Thu T., Pinlac, Geraldine, Reynolds, Annie ... Johnson, David W. (2023). Multi-center, pragmatic, cluster-randomized, controlled trial of standardized peritoneal dialysis (PD) training versus usual care on PD-related infections (the TEACH-PD trial): trial protocol. Trials, 24 (1) 730, 730. doi: 10.1186/s13063-023-07715-0

Viecelli, Andrea K., Teixeira-Pinto, Armando, Valks, Andrea, Baer, Richard, Cherian, Roy, Cippà, Pietro E., Craig, Jonathan C., DeSilva, Ranil, Jaure, Allison, Johnson, David W., Kiriwandeniya, Charani, Kopperschmidt, Pascal, Liu, Wen-J, Lee, Timmy, Lok, Charmaine, Madhan, Krishan, Mallard, Alistair R., Oliver, Veronica, Polkinghorne, Kevan R., Quinn, Rob R., Reidlinger, Donna, Roberts, Matthew, Sautenet, Bénédicte, Hooi, Lai Seong, Smith, Rob, Snoeijs, Maarten, Tordoir, Jan, Vachharajani, Tushar J., Vanholder, Raymond ... on behalf of the VALID Investigator Team (2022). Study protocol for Vascular Access outcome measure for function: a vaLidation study In hemoDialysis (VALID) : A multi-center, multinational validation study to assess the accuracy and feasibility of measuring vascular access function in clinical practice. BMC Nephrology, 23 (1) 372, 1-12. doi: 10.1186/s12882-022-02987-1

Collins, Michael G., Fahim, Magid A., Pascoe, Elaine M., Hawley, Carmel M., Johnson, David W., Varghese, Julie, Hickey, Laura E., Clayton, Philip A., Gill, John S., Dansie, Kathryn B., McConnochie, Rachael C., Vergara, Liza A., Kiriwandeniya, Charani, Reidlinger, Donna, Mount, Peter F., Weinberg, Laurence, McArthur, Colin J., Toby Coates, P., Endre, Zoltan H., Goodman, David, Howard, Kirsten, Howell, Martin, Jamboti, Jagadish S., Kanellis, John, Laurence, Jerome M., Lim, Wai H., McTaggart, Steven J., O'Connell, Philip J., Pilmore, Helen L. ... on behalf of the BEST-Fluids Investigators and the Australasian Kidney Trials Network (2022). Baseline Characteristics and Representativeness of Participants in the BEST-Fluids Trial: A Randomized Trial of Balanced Crystalloid Solution Versus Saline in Deceased Donor Kidney Transplantation. Transplantation Direct, 8 (12) e1399, 1-13. doi: 10.1097/TXD.0000000000001399

van Zwieten, Anita, Ryan, Elizabeth G., Caldwell, Patrina, Howard, Kirsten, Tong, Allison, Craig, Jonathan C., Alexander, Stephen I., Howell, Martin, Teixeira-Pinto, Armando, Hawley, Carmel M., Jesudason, Shilpanjali, Walker, Amanda, Mackie, Fiona, Kennedy, Sean E., McTaggart, Steven, McCarthy, Hugh J., Carter, Simon A., Kim, Siah, Woodleigh, Reginald, Francis, Anna, Mallard, Alistair R., Bernier-Jean, Amélie, Johnson, David W., Hahn, Deirdre, Reidlinger, Donna, Pascoe, Elaine, Varghese, Julie, Kiriwandeniya, Charani, Vergara, Liza ... Wong, Germaine (2022). NAVKIDS2 trial: a multi-centre, waitlisted randomised controlled trial of a patient navigator intervention in children with chronic kidney disease — statistical analysis plan and update to the protocol. Trials, 23 (1) 824. doi: 10.1186/s13063-022-06783-y

Tiong, Mark K., Krishnasamy, Rathika, Smith, Edward R., Hutchison, Colin A., Ryan, Elizabeth G., Pascoe, Elaine M., Hawley, Carmel M., Hewitson, Tim D., Jardine, Meg J., Roberts, Matthew A., Cho, Yeoungjee, Wong, Muh Geot, Heath, Anne, Nelson, Craig L., Sen, Shaundeep, Mount, Peter F., Vergara, Liza A., Paul-Brent, Peta-Anne, Johnson, David W. and Toussaint, Nigel D. (2021). Effect of a medium cut-off dialyzer on protein-bound uremic toxins and mineral metabolism markers in patients on hemodialysis. Hemodialysis International, 25 (3), 322-332. doi: 10.1111/hdi.12924

Robison, Laura, Cho, Yeoungjee, Viecelli, Andrea K., Johnson, David W., Hawley, Carmel M., Valks, Andrea, Paul-Brent, Peta-Anne, Stastny, Ruth, Varghese, Julie, Kiriwandeniya, Charani, Pascoe, Elaine M., Vergara, Liza A., Fahim, Magid A., Boudville, Neil, Krishnasamy, Rathika and Reidlinger, Donna (2021). Conducting clinical trials during the COVID-19 pandemic-a collaborative trial network response. Trials, 22 (1) 278, 278. doi: 10.1186/s13063-021-05200-0

Collins, Michael G., Fahim, Magid A., Pascoe, Elaine M., Dansie, Kathryn B., Hawley, Carmel M., Clayton, Philip A., Howard, Kirsten, Johnson, David W., McArthur, Colin J., McConnochie, Rachael C., Mount, Peter F., Reidlinger, Donna, Robison, Laura, Varghese, Julie, Vergara, Liza A., Weinberg, Laurence and Chadban, Steven J. (2020). Study protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): A pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation. Trials, 21 (1) 428, 428. doi: 10.1186/s13063-020-04359-2

Krishnasamy, Rathika, Hawley, Carmel M., Jardine, Meg J., Roberts, Matthew A., Cho, Yeoungjee, Wong, Muhgeot, Heath, Anne, Nelson, Craig L., Sen, Shaundeep, Mount, Peter F., Pascoe, Elaine M., Vergara, Liza A., Paul-Brent, Peta-Anne, Toussaint, Nigel D., Johnson, David W. and Hutchison, Colin A. (2020). A tRial evaluating mid cut-off value membrane clearance of albumin and light chains in HemoDialysis patients: a safety device study. Blood Purification, 49 (4), 1-11. doi: 10.1159/000505567

Krishnasamy, R., Hawley, C. M., Jardine, M. J., Roberts, M. A., Cho, Y. J., Wong, M. G., Heath, A., Nelson, C. L., Sen, S., Mount, P. F., Pascoe, E. M., Darssan, D., Vergara, L. A., Paul-Brent, P. A., Toussaint, N. D., Johnson, D. W. and Hutchison, C. A. (2018). Design and methods of the REMOVAL-HD study: a tRial evaluating mid cut-off value membrane clearance of albumin and light chains in HaemoDialysis patients. BMC Nephrology, 19 (1) 89, 89. doi: 10.1186/s12882-018-0883-8

Roberts, Matthew A., Darssan, Darsy, Badve, Sunil V., Carroll, Robert P., Fahim, Magid A., Haluska, Brian A., Hawley, Carmel M., Isbel, Nicole M., Marshall, Mark R., Pascoe, Elaine M., Pedagogos, Eugenie, Pilmore, Helen L., Snelling, Paul, Stanton, Tony, Tan, Ken-Soon, Tonkin, Andrew M., Vergara, Liza A. and Ierino, Francesco L. (2017). Carvedilol and cardiac biomarkers in dialysis patients: secondary analysis of a randomized controlled trial. Kidney and Blood Pressure Research, 42 (6), 1033-1044. doi: 10.1159/000485589

Zhang, Lei, Badve, Sunil V., Pascoe, Elaine M., Beller, Elaine, Cass, Alan, Clark, Carolyn, de Zoysa, Janak, Isbel, Nicole M., Liu, Xusheng, McTaggart, Steven, Morrish, Alicia T., Playford, Geoffrey, Scaria, Anish, Snelling, Paul, Vergara, Liza A., Hawley, Carmel M., Johnson, David W. and for the HONEYPOT Study Collaborative Group (2017). Representativeness of honeypot trial participants to Australasian PD patients. Peritoneal Dialysis International, 37 (5), 516-522. doi: 10.3747/pdi.2016.00065

Gummer, Joel, Trengove, Robert, Pascoe, Elaine M., Badve, Sunil V., Cass, Alan, Clarke, Philip, McDonald, Stephen P., Morrish, Alicia T., Pedagogos, Eugenie, Perkovic, Vlado, Reidlinger, Donna, Scaria, Anish, Walker, Rowan, Vergara, Liza A., Hawley, Carmel M., Johnson, David W., Olynyk, John K. and Ferrari, Paolo (2017). Association between serum hepcidin-25 and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial. Nephrology, 22 (7), 548-554. doi: 10.1111/nep.12815

Zhang, Lei, Coombes, Jeff, Pascoe, Elaine M., Badve, Sunil V., Dalziel, Kim, Cass, Alan, Clarke, Philip, FerrarI, Paolo, McDonald, Stephen P., Morrish, Alicia T., Pedagogos, Eugenie, Perkovic, Vlado, Reidlinger, Donna, Scaria, Anish, Walker, Rowan, Vergara, Liza A., Hawley, Carmel M. and Johnson, David W. (2016). The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: sub-study of the HERO trial.. Redox Report, 21 (1), 14-23. doi: 10.1179/1351000215Y.0000000022

Roberts, Matthew A., Pilmore, Helen L., Ierino, Francesco L., Badve, Sunil V., Cass, Alan, Garg, Amit X., Isbel, Nicole M., Krum, Henry, Pascoe, Elaine M., Perkovic, Vlado, Scaria, Anish, Tonkin, Andrew M., Vergara, Liza A., Hawley, Carmel M., BLOCADE Study Collaborative Group and Reidlinger, Donna (2015). The β-Blocker to lower cardiovascular dialysis events (BLOCADE) feasibility study: a randomized controlled trial. American Journal of Kidney Diseases, 67 (6), 902-911. doi: 10.1053/j.ajkd.2015.10.029

Zhang, Lei, Badve, Sunil V., Pascoe, Elaine M., Beller, Elaine, Cass, Alan, Clark, Carolyn, de Zoysa, Janak, Isbel, Nicole M., McTaggart, Steven, Morrish, Alicia T., Playford, E. Geoffrey, Scaria, Anish, Snelling, Paul, Vergara, Liza A., Hawley, Carmel M. and Johnson, David W. (2015). The effect of exit-site antibacterial honey versus nasal mupirocin prophylaxis on the microbiology and outcomes of peritoneal dialysis-associated peritonitis and exit-site infections: a sub-study of the honeypot trial. Peritoneal Dialysis International, 35 (7), 712-721. doi: 10.3747/pdi.2014.00206

Badve, Sunil V., Zhang, Lei, Coombes, Jeff S., Pascoe, Elaine M., Cass, Alan, Clarke, Philip, Ferrari, Paolo, McDonald, Stephen P., Alicia T. Morrish, Eugenie Pedagogos, Vlado Perkovic, Donna Reidlinger, Anish Scaria, Rowan Walker, Liza A. Vergara, Carmel M. Hawley, David W. Johnson and and on behalf of the HERO Study Collaborative Group (2015). Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial. Canadian Journal of Kidney Health and Disease, 2 (33) 33, 1-10. doi: 10.1186/s40697-015-0066-5

Roberts, Matthew A., Pilmore, Helen L., Ierino, Francesco L., Badve, Sunil V., Cass, Alan, Garg, Amit X., Hawley, Carmel M., Isbel, Nicole M., Krum, Henry, Pascoe, Elaine M., Tonkin, Andrew M., Vergara, Liza A., Perkovic, Vlado and The BLOCADE Study Collaborative Group (2015). The rationale and design of the beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) feasibility study. Nephrology, 20 (3), 140-147. doi: 10.1111/nep.12362

Johnson, David W., Pascoe, Elaine M., Badve, Sunil V., Dalziel, Kim, Cass, Alan, Clarke, Philip, Ferrari, Paolo, McDonald, Stephen P., Morrish, Alicia T., Pedagogos, Eugenie, Perkovic, Vlado, Reidlinger, Donna, Scaria, Anish, Walker, Rowan, Vergara, Liza A., Hawley, Carmel M., on behalf of the HERO Study Collaborative Group and Fassett, Rob (2015). A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the handling erythropoietin resistance with oxpentifylline (HERO) trial. American Journal of Kidney Diseases, 65 (1), 49-57. doi: 10.1053/j.ajkd.2014.06.020

Johnson, David W., Badve, Sunil V., Pascoe, Elaine M., Beller, Elaine, Cass, Alan, Clark, Carolyn, de Zoysa, Janak, Isbel, Nicole M., McTaggart, Steven, Morrish, Alicia T., Playford, E. Geoffrey, Scaria, Anish, Snelling, Paul, Vergara, Liza A., Hawley, Carmel M. and for the HONEYPOT Study Collaborative Group (2014). Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): A randomised trial. The Lancet Infectious Diseases, 14 (1), 23-30. doi: 10.1016/S1473-3099(13)70258-5

Roberts, Matthew A., Pilmore, Helen L., Tonkin, Andrew M., Garg, Amit X., Pascoe, Elaine M., Badve, Sunil V., Cass, Alan, Ierino, Francesco L., Hawley, Carmel M., Beta-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study, Isbel, Nicole, Thompson, Charles and Vergara, Liza (2012). Challenges in blood pressure measurement in patients treated with maintenance hemodialysis. American Journal of Kidney Diseases, 60 (3), 463-472. doi: 10.1053/j.ajkd.2012.04.026

Miller, Lance D., Smeds, Johanna, George, Joshy, Vega, Vinsensius B., Vergara, Liza, Ploner, Alexander, Pawitan, Yudi, Hall, Per, Klaar, Sigrid, Liu, Edison T. and Bergh, Jonas (2005). An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proceedings of the National Academy of Sciences, 102 (38), 13550-13555. doi: 10.1073/pnas.0506230102

Lin, Chin-Yo, Ström, Anders, Vega, Vinsensius Berlian, Kong, Say Li, Yeo, A. L., Thomsen, Jane S., Chan, Wan Ching, Doray, Balraj, Bangarusamy, Dhinoth K., Ramasamy, Adaikalavan, Vergara, Liza A., Tang, Suisheng, Chong, Allen, Bajic, Vladimir B., Miller, Lance D., Gustafsson, Jan-Ake and Liu, Edison T. (2004). Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells. Genome Biology, 5 (9) R66. doi: 10.1186/gb-2004-5-9-r66

Pascoe, Elaine, Darssan, Darsy and Vergara, Liza A. (2017). Use of minimization in multi- center clinical trials - when to not add randomization. 4th International Clinical Trials Methodology Conference (ICTMC), Liverpool, United Kingdom, 7-10 May 2017. London, United Kingdom: BioMed Central.

Roberts, M., Badve, S., Carroll, R., Darssan, D., Fahim, M., Hawley, C., Isbel, N., Marshall, M., Pascoe, E., Pedagogos, E., Pilmore, H., Snelling, P., Tan, K., Tonkin, A., Vergara, L. and Ierino, F. (2016). Effect of the Beta-Blocker Carvedilol On Biomarkers of Cardiovascular Disease in Patients Receiving Dialysis. The 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth, WA Australia, 17–21 September 2016. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia.

Roberts, M., Badve, S., Carroll, R., Darssan, D., Fahim, M., Hawley, C., Isbel, N., Marshall, M., Pascoe, E., Pedagogos, E., Pilmore, H., Snelling, P., Tan, K., Tonkin, A., Vergara, L. and Ierino, F. (2016). Cardiovascular Biomarkers, Global Left Ventricular Strain, and Tolerability of the Beta-Blocker Carvedilol in Patients Receiving Dialysis. The 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth, WA, Australia, 17–21 September 2016. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia.

Zhang, L., Pascoe, E. M., Badve, S. V., Cass, A., Clarke, P., Coombes, J. S., Ferrari, P., Mcdonald, S. P., Morrish, A. T., Pedagogos, E., Perkovic, V., Reidlinger, D., Scaria, A., Walker, R., Vergara, L. A., Hawley, C. M. and Johnson, D. W. (2014). The effect of pentoxifylline on oxidative stress markers: substudy of the hero trial. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, VIC, Australia, 25-27 August 2014. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12301

Zhang, L., Badve, S. V., Pascoe, E. M., Beller, E., Cass, A., Clark, C., De Zoysa, J., Isbel, N. M., Mctaggart, S., Morrish, A. T., Playford, E. G., Scaria, A., Snelling, P., Vergara, L. A., Hawley, C. M., Johnson, D. W. and Honeypot Study Collaborative Group (2014). Microbiological results of the Honeypot Study - Secondary analysis of a randomised, controlled trial of exit site application of Medihoney for the prevention of catheter-associated infections in Pd patients. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25–27 August 2014. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12301

Johnson, D. W., Pascoe, E., Badve, S. V., Dalziel, K., Cass, A., Clarke, P., Ferrari, P., Mcdonald, S. P., Morrish, A. T., Pedagogos, E., Perkovic, V., Scaria, A., Walker, R., Vergara, L. A. and Hawley, C. M. (2014). A Randomized, Placebo-Controlled Trial of Pentoxifylline On Erythropoiesis Stimulating Agent Resistance in Anaemic Patients with Chronic Kidney Disease - the Hero Trial. Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25–27 August 2014. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/nep.12301

Badve, S. V., Pascoe, E. M., Cass, A., Clarke, P., Coombes, J., Ferrari, P., Mcdonald, S. P., Morrish, A. T., Pedagogos, E., Perkovic, V., Reidlinger, D., Scaria, A., Walker, R., Vergara, L. A., Hawley, C. M. and Johnson, D. W. (2014). Association Between Serum Alkaline Phosphatase and Resistance to Erythropoiesis Stimulating Agents in Chronic Kidney Disease: a Post-Hoc Analysis of the Hero Trial. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourme, VIC Australia, 25-27 August 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12301

Dr Liza Vergara

Publications

Journal Articles

Conference Papers